Celltrion, Inc. Stock
Stocks
A068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Korea S.E.
2026-11-11
|
5-day change | 1st Jan Change | ||
| 207,000.00 KRW | +1.97% |
|
+3.50% | +20.08% |
| Nov. 09 | Celltrion's Stekima Wins EU Backing for Expanded Use in Children | MT |
| Nov. 02 | Celltrion Gets European Approval for Rheumatoid Arthritis Drug Trial | MT |
| Market Cap | 47,286B 35.34B 31.85B 29.43B 26.6B 50.33B 3,315B 51.58B 353B 141B 1,775B 133B 130B 5,650B | P/E 2026 * |
35.1x | P/E 2027 * | 26.3x |
|---|---|---|---|---|---|
| Enterprise Value | 49.85B 37.26M 33.58M 31.03M 28.05M 53.06M 3.49B 54.37M 372M 148M 1.87B 140M 137M 5.96B | EV / Sales 2026 * |
8.67x | EV / Sales 2027 * | 7.49x |
| Free-Float |
58.02% | Yield 2026 * |
0.37% | Yield 2027 * | 0.39% |
| 1 day | +1.97% | ||
| 1 week | +3.50% | ||
| Current month | +8.04% | ||
| 1 month | +15.26% | ||
| 3 months | -1.66% | ||
| 6 months | +13.62% | ||
| Current year | +20.08% |
| 1 week | 202,000 |  | 216,000 |
| 1 month | 173,700 | | 216,000 |
| Current year | 158,500 | | 239,047.62 |
| 1 year | 158,500 | | 239,047.62 |
| 3 years | 135,879.99 | | 239,047.62 |
| 5 years | 114,250.83 | | 239,047.62 |
| 10 years | 64,487.59 | | 325,235.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 2015-03-19 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 2021-03-25 |
Hyeok-Jae Lee
PSD | President | 51 | 2026-02-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 69 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 2005-03-31 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/16/26 | Sell | 500 | 0.0002% | |||
| 1/16/26 | Sell | 1,000 | 0.0004% | |||
| 1/16/26 | Sell | 1,000 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.97% | +3.50% | +25.78% | +50.98% | 35.34B | |
| -1.06% | -0.07% | +60.76% | +68.61% | 67.53B | |
| +1.44% | +8.88% | +14.14% | +93.00% | 60.74B | |
| +0.66% | -0.86% | +20.19% | +98.63% | 55.66B | |
| -0.95% | +11.17% | +22.21% | +110.93% | 47.97B | |
| -0.23% | +4.07% | +25.63% | +40.08% | 45.24B | |
| -6.40% | -9.51% | +181.99% | +816.79% | 39.08B | |
| -0.49% | -2.61% | +80.11% | +56.78% | 33.45B | |
| +1.05% | +9.77% | -37.66% | +408.42% | 26.49B | |
| 0.00% | +0.41% | +46.52% | +0.16% | 25.57B | |
| Average | -0.40% | +1.64% | +43.97% | +174.44% | 44B | |
| Weighted average by Cap. | -0.39% | +1.61% | +43.94% | +158.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,751B 4.3B 3.87B 3.58B 3.24B 6.12B 403B 6.27B 42.9B 17.1B 216B 16.13B 15.79B 687B | 6,561B 4.9B 4.42B 4.08B 3.69B 6.98B 460B 7.16B 48.94B 19.51B 246B 18.41B 18.01B 784B |
| Net income | 1,341B 1B 904M 835M 755M 1.43B 94.03B 1.46B 10B 3.99B 50.36B 3.76B 3.68B 160B | 1,814B 1.36B 1.22B 1.13B 1.02B 1.93B 127B 1.98B 13.53B 5.39B 68.1B 5.09B 4.98B 217B |
| Net Debt | 2,566B 1.92B 1.73B 1.6B 1.44B 2.73B 180B 2.8B 19.14B 7.63B 96.32B 7.2B 7.04B 307B | 1,849B 1.38B 1.25B 1.15B 1.04B 1.97B 130B 2.02B 13.79B 5.5B 69.43B 5.19B 5.08B 221B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-11 | ₩207,000.00 | +1.97% | 745,716 |
| 26-11-10 | ₩203,000.00 | -3.33% | 869,506 |
| 26-11-09 | ₩210,000.00 | -0.47% | 626,672 |
| 26-11-06 | ₩211,000.00 | -1.86% | 1,036,846 |
| 26-11-05 | ₩215,000.00 | +7.50% | 1,999,977 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- A068270 Stock
Select your edition
All financial news and data tailored to specific country editions
